|Articles|January 27, 2021

Supplements and Featured Publications

  • The Role of Lipoprotein(a) As a Biomarker to Assess Cardiovascular Risk

The Role of Lipoprotein(a) As a Biomarker to Assess Cardiovascular Risk

This publication is sponsored by Novartis AG.

This Clinical Practice Brief provides an overview of the genetic cardiovascular risk biomarker lipoprotein a (Lp[a]), as well as its importance as an independent risk factor for cardiovascular disease, the prevalence of elevated Lp(a) levels among the global population, and recommendations for lipid management.


Related to this article